CN111418841A - Dietary supplement for promoting microcirculation - Google Patents

Dietary supplement for promoting microcirculation Download PDF

Info

Publication number
CN111418841A
CN111418841A CN202010454764.3A CN202010454764A CN111418841A CN 111418841 A CN111418841 A CN 111418841A CN 202010454764 A CN202010454764 A CN 202010454764A CN 111418841 A CN111418841 A CN 111418841A
Authority
CN
China
Prior art keywords
parts
dietary supplement
raw materials
microcirculation
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010454764.3A
Other languages
Chinese (zh)
Inventor
王璐林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010454764.3A priority Critical patent/CN111418841A/en
Publication of CN111418841A publication Critical patent/CN111418841A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/344—Codonopsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

A dietary supplement for promoting microcirculation, characterized by: is prepared from the following raw materials: chinese angelica root, notoginseng, safflower. The beneficial effects are that: the health-care food can promote blood circulation of a human body, dredge microcirculation disturbance, increase bone density and obviously improve the health level of the human body, has no toxic or side effect, can be taken for a long time, and is suitable for people with weak constitution and pathological changes or symptoms of bone tissues.

Description

Dietary supplement for promoting microcirculation
Technical Field
The invention relates to a dietary supplement which takes plants as main raw materials, has the potential of promoting blood circulation, strengthening physique and exciting self-protection and repair of human bodies, and particularly can improve human microcirculation and prevent and repair decay or damage of bone tissues.
Background
The blood circulation is the basis of energy supplement and metabolism of human bodies, and various diseases can be caused by the unsmooth blood circulation. In particular, the microcirculation supplements the body's material needs by exchanging material between the blood and interstitial fluid. Under normal conditions, the blood flow of microcirculation adapts to the metabolism level of tissues and organs, and the blood perfusion of each tissue and organ can be ensured and the blood volume of returning heart can be adjusted. If the microcirculation is disturbed, the physiological functions of each organ will be directly affected. Microcirculatory disturbances are in many forms, but the more common outward manifestations are mainly physical weakness and decay of muscle or bone tissue. The physical weakness is manifested by general malaise, shortness of breath, weakness, difficulty in movement, insomnia, dysphoria, frequent cold, etc., and is often accompanied with various degenerative processes of people. The decay of muscle tissue is usually manifested as muscle relaxation, frequent sores and ulcers, and unhealed wounds. The bone tissue decay is usually manifested as osteoporosis, bone fracture, chondritis, osteomyelitis, bone tuberculosis, bone cyst, femoral head injury or necrosis.
In the past, the decay of the body caused by blood circulation disorder, especially the inflammation and injury of bone tissue, is treated according to pathological changes, and most of them are treated by medication or operation. The period of drug treatment is long and the curative effect is uncertain. Many drugs also have toxic side effects and are not suitable for long-term administration. Surgical treatments are more traumatic, more costly, and often come at the expense of loss of local tissue and function. Therefore, it is preferable to prevent or repair the above-mentioned body decay phenomenon, particularly degeneration or damage of bone tissue, by dredging blood circulation paths and eliminating microcirculation disturbance before occurrence or at the beginning of discovery. Obviously, in order to achieve the purpose, the existing treatment concept and method are changed, and the purposes of promoting blood circulation to remove blood stasis and preventing and repairing micro-disorders are achieved through dietary supplement in daily life. Dietary supplements that achieve these objectives are currently scarce.
Disclosure of Invention
The invention aims to provide a dietary supplement which can dredge the blood circulation path of a human body, promote microcirculation, prevent or repair microcirculation disturbance, particularly strengthen the physique, improve and reverse decay and injury of bone tissues, supplement nutrient substances required by the movement of the human body, maintain the physiological functions of bones and muscles, has no toxic or side effect, and can be taken for a long time.
The above purpose is realized by the following technical scheme: provides a dietary supplement for promoting blood circulation, strengthening bones and promoting tissue regeneration, and promoting the repair of bone, cartilage and muscle decay injuries, which is characterized in that: the dietary supplement is prepared from the following raw materials: earthworm, pearl, angelica and pseudo-ginseng.
The weight parts of the raw materials are as follows: 80-100 parts of earthworm, 8-12 parts of pearl, 80-100 parts of angelica and 55-65 parts of pseudo-ginseng.
Safflower and borneol are added into the raw materials according to the weight portion.
12-18 parts of safflower and 2-5 parts of borneol are added into the raw materials according to the parts by weight.
The raw materials are added with rhizoma ligustici wallichii and codonopsis pilosula according to the weight parts.
The raw materials are added with 25 to 35 parts of rhizoma ligustici wallichii and 80 to 100 parts of radix codonopsis according to the weight parts.
The cerasus humilis and the American ginseng are added into the raw materials according to the weight parts.
5-7 parts of cerasus humilis and 2-5 parts of American ginseng are added into the raw materials according to the parts by weight.
The invention has the beneficial effects that: the dietary supplement can promote blood circulation of a human body, dredge microcirculation disturbance, increase bone density, remarkably improve the health level of the human body, has no toxic or side effect, can be taken for a long time, and is suitable for people with weak constitution and pathological signs or symptoms of muscle tissues or bone tissues.
Detailed Description
The first embodiment: the dietary supplement for promoting blood circulation, strengthening bone and promoting tissue regeneration is prepared from the following raw materials: earthworm, pearl, angelica and pseudo-ginseng.
The weight parts of the raw materials are as follows: 80-100 parts of earthworm, 8-12 parts of pearl, 80-100 parts of angelica and 55-65 parts of pseudo-ginseng.
The optimized weight portion ratio of the raw materials is as follows: 90 parts of earthworm, 10 parts of pearl, 90 parts of angelica and 60 parts of pseudo-ginseng.
The above raw materials are illustrated as follows:
earthworm, Earthworm earth, also known as ricefield eel, is a representative animal of the oligochaeta of Annelida. Is one of the important Chinese medicinal materials. Is a nutrient source integrating protein, vitamin, mineral substances and enzyme substances.
Pearl Pernulo is a lustrous granule formed in the pearl sac of several pearl shells, and is a nutrient source integrating minerals, amino acids and nutrients.
Angelica Sinensis, named Radix Angelica Sinensis Sinensis of Latin school, belongs to Umbelliferae perennial herb, and the root of Angelica Sinensis is the most commonly used Chinese medicine.
Pseudo-ginseng (Latin scientific name: Panax pseudo-ginseng wall. var. notogenseng (Burkill) Hoo et Tseng) is a perennial herb of Panax of Araliaceae of Umbelliferae, the root of the plant is used as a medicine, and the research proves that the pseudo-ginseng has the function of improving microcirculation.
There are several methods of processing and administering the dietary supplement, and these examples are merely two:
pulverizing the above materials, sieving with 80 mesh sieve, and making into decoction, powder, pill, tablet, or capsule. The composition is administered orally by adult in an amount of 2-3 g three times a day.
Pulverizing the above materials, decocting in water, and making decoction or concentrating into decoction, powder, pill, tablet, or capsule. The administration method is that the medicine is orally taken by adults for 1-2g each time and three times a day.
Safety: experiments prove that the raw materials are safe and nontoxic, and the required dosage is lower than the related specified dosage, so that the raw materials can be completely determined to be safe. Nevertheless, the study was conducted with standardized animal and clinical trials, which demonstrated that the above combinations were safe. Only two experimental cases are described below:
firstly, weak people experiment: the weakness mainly refers to physical weakness, discomfort of the whole body, weakness after illness, postpartum weakness, shortness of breath, difficulty in walking, insomnia, amnesia and the like caused by poor blood circulation.
Two, zero, one and zero years ago, a microcirculation multi-parameter measuring instrument is adopted to detect three 16 indexes of the nail fold microcirculation pipe loop shape, the blood flow state, the surrounding state of the pipe loop and the like of a plurality of weak people, and the people with abnormal indexes take the dietary supplement. The recovery is that the index is improved, the senile state disappears and the disease does not recur after one-year return visit. Recovery number/total number x100% = recovery rate; the experimental conditions are as follows:
Figure 333837DEST_PATH_IMAGE001
the product has good repairing and improving effects on various microcirculation disorders.
II, bone mineral density experiment of the general population: in the process of a large number of medicinal experimental researches, the product is suitable for being used as a dietary supplement for common people, can be continuously taken for a long time, and can obviously improve the common decline signs of middle-aged and old people such as bone density reduction, physical quality reduction, insomnia, amnesia, waist and back pain and the like. Since the change in bone density has a typical meaning, many comparative experiments have been performed since 2017. An experimental example is now introduced:
60 experimenters are collected according to the voluntary principle, the age is between 50 and 65, the bone density detection is carried out by a regular hospital, and the T values of the bone density are all between-2.5 and-1 and are all people with slightly low bone density. Wherein 30 people in the experimental group take the product. The control group 30 patients took 1-2g calcium carbonate tablets per day. After taking for 6 months continuously, the detection is carried out, the T value is recovered when the T value is increased to-1, the T value is not changed and maintained, the T value is further reduced to be ineffective, and the results are as follows:
Figure 37089DEST_PATH_IMAGE002
the experimental results show that the product has a remarkable administration effect, particularly, the physical conditions of diet, sleep, defecation and the like of the experimental group are good, the product is required to be taken continuously, and the comprehensive evaluation is obviously superior to that of the control group.
The second embodiment: safflower and borneol are added into the raw materials of the first embodiment. Forming a reinforced formula: 80-100 parts of earthworm, 8-12 parts of pearl, 80-100 parts of angelica, 55-65 parts of pseudo-ginseng, 12-18 parts of safflower and 2-5 parts of borneol. Preferably 90 parts of earthworm, 10 parts of pearl, 90 parts of angelica, 60 parts of pseudo-ginseng, 15 parts of safflower and 3 parts of borneol.
Brief introduction of newly added raw materials:
safflower (Carthamus tinctorius L, the name of Latin is Carthamus tinctorius, Compositae and Carthamus plants, which are traditional Chinese medicinal herbs, and the research mainly utilizes the functions of the safflower of promoting blood circulation and removing blood stasis and dredging blood microcirculation.
Borneol and natural crystalline compound precipitated from resin of Dipterocarpaceae.
The processing, administration, safety and experimental methods of the dietary supplement were the same as in the first example: only two experimental cases are described below:
the experimental conditions of the weak people are as follows:
Figure 767148DEST_PATH_IMAGE003
the product has good repairing and improving effects on various microcirculation disorders.
II, bone mineral density experiment of the general population: in the process of a large number of medicinal experimental researches, the product is suitable for being used as a dietary supplement for common people, can be continuously taken for a long time, and can obviously improve the common decline signs of middle-aged and old people such as bone density reduction, physical quality reduction, insomnia, amnesia, waist and back pain and the like. Since the change in bone density has a typical meaning, many comparative experiments have been performed since 2017. An experimental example is now introduced:
60 experimenters are collected according to the voluntary principle, the age is between 50 and 65, the bone density detection is carried out by a regular hospital, and the T values of the bone density are all between-2.5 and-1 and are all people with slightly low bone density. Wherein 30 people in the experimental group take the product. The control group 30 patients took 1-2g calcium carbonate tablets per day. After taking for 6 months continuously, the detection is carried out, the T value is recovered when the T value is increased to-1, the T value is not changed and maintained, the T value is further reduced to be ineffective, and the results are as follows:
Figure 842551DEST_PATH_IMAGE004
the experimental results show that the product has a remarkable administration effect, particularly, the physical conditions of diet, sleep, defecation and the like of the experimental group are good, the product is required to be taken continuously, and the comprehensive evaluation is obviously superior to that of the control group.
Third embodiment: rhizoma ligustici wallichii and codonopsis pilosula are added into the raw materials of the first embodiment. Forming an enhanced formula: 80-100 parts of earthworm, 8-12 parts of pearl, 80-100 parts of angelica, 55-65 parts of pseudo-ginseng, 25-35 parts of ligusticum wallichii and 80-100 parts of codonopsis pilosula. Preferably 90 parts of earthworm, 10 parts of pearl, 60 parts of pseudo-ginseng, 30 parts of ligusticum wallichii and 90 parts of codonopsis pilosula.
Brief introduction of newly added raw materials:
ligusticum wallichii (with the scientific name of L igustrium chuanxiong hort) is a Chinese medicinal plant.
Dangshen (academic name;Codonopsis pilosula(Franch.) Nannf.) perennial herb of Codonopsis genus of Campanulaceae family.
The processing, administration, safety and experimental methods of the dietary supplement were the same as in the first example. Only two experimental cases are described below:
the experimental conditions of the weak people are as follows:
Figure 367073DEST_PATH_IMAGE005
the product has good repairing and improving effects on various microcirculation disorders.
II, bone mineral density experiment of the general population:
60 experimenters are collected according to the voluntary principle, the age is between 50 and 65, the bone density detection is carried out by a regular hospital, and the T values of the bone density are all between-2.5 and-1 and are all people with slightly low bone density. Wherein 30 people in the experimental group take the product. The control group 30 patients took 1-2g calcium carbonate tablets per day. After taking for 6 months continuously, the detection is carried out, the T value is recovered when the T value is increased to-1, the T value is not changed and maintained, the T value is further reduced to be ineffective, and the results are as follows:
Figure 527927DEST_PATH_IMAGE006
the experimental results show that the product has a remarkable administration effect, particularly, the physical conditions of diet, sleep, defecation and the like of the experimental group are good, the product is required to be taken continuously, and the comprehensive evaluation is obviously superior to that of the control group.
The fourth embodiment: adding Prunus humilis Bunge and radix Panacis Quinquefolii into Lumbricus, Margarita, radix Angelicae sinensis and Notoginseng radix. 80-100 parts of earthworm, 2-5 parts of pearl, 55-65 parts of pseudo-ginseng, 5-7 parts of cerasus humilis and 2-5 parts of American ginseng.
Preferably 300 parts of angelica, 60 parts of pseudo-ginseng, 15 parts of safflower, 6 parts of cerasus humilis and 3 parts of American ginseng.
Brief introduction of newly added raw materials:
cerasus humilis (Bge) Sok) has high calcium content in its fruit and is also called high calcium fruit. Angiosperma belongs to the genus cerasus of the family Rosaceae of the order Rosales of the order dicotyledonae. The kernel has the actions of inducing diuresis and slowing down, and is mainly used for dry stool and difficult urination. The fruit is sour, sweet and delicious, has unique flavor and rich nutrition, and the content of calcium and iron is the highest in the fruit. Every 100 g pulp contains 360 mg calcium and 58 mg iron.
American ginseng (scientific name: Panax quinquefolius) is a perennial plant of Panax of Araliaceae, and is also called American ginseng, etc.
The processing, administration, safety and experimental methods of the dietary supplement were the same as in the fourth example. Only two experimental cases are described below:
the experimental conditions of the weak people are as follows:
Figure 530518DEST_PATH_IMAGE007
the product has good repairing and improving effects on various microcirculation disorders, and the effect-taking time is obviously shortened.
II, 7 bone mineral density experiment of common population:
60 experimenters are collected according to the voluntary principle, the age is between 50 and 65, the bone density detection is carried out by a regular hospital, and the T values of the bone density are all between-2.5 and-1 and are all people with slightly low bone density. Wherein 30 people in the experimental group take the product. The control group 30 patients took 1-2g calcium carbonate tablets per day. After taking for 6 months continuously, the detection is carried out, the T value is recovered when the T value is increased to-1, the T value is not changed and maintained, the T value is further reduced to be ineffective, and the results are as follows:
type (B) Total number (human) Recovery Maintenance of Invalidation
Control group 30 10 12 8
Experimental group 30 25 5 0
The experimental results show that the product has a remarkable administration effect, particularly, the physical conditions of diet, sleep, defecation and the like of the experimental group are good, the product is required to be taken continuously, and the comprehensive evaluation is obviously superior to that of the control group.

Claims (8)

1. A dietary supplement for promoting microcirculation, characterized by: the dietary supplement is prepared from the following raw materials: earthworm, pearl, angelica and pseudo-ginseng.
2. A dietary supplement for promoting microcirculation according to claim 1, wherein: the weight parts of the raw materials are as follows: 80-100 parts of earthworm, 8-12 parts of pearl, 80-100 parts of angelica and 55-65 parts of pseudo-ginseng.
3. A dietary supplement for promoting microcirculation according to claim 1, wherein: safflower and borneol are added into the raw materials according to the weight portion.
4. A dietary supplement for promoting microcirculation according to claim 2, wherein: 12-18 parts of safflower and 2-5 parts of borneol are added into the raw materials according to the parts by weight.
5. A micro-circulating dietary supplement according to claim 1, characterized in that: rhizoma Ligustici Chuanxiong and radix Codonopsis are added into the above raw materials.
6. A dietary supplement for promoting microcirculation according to claim 2, wherein: 25-35 parts of ligusticum wallichii and 180-220 parts of codonopsis pilosula are added into the raw materials according to the parts by weight.
7. A dietary supplement for promoting microcirculation according to claim 1, wherein: the cerasus humilis and the American ginseng are added into the raw materials.
8. A dietary supplement for promoting microcirculation according to claim 2, wherein: 5-7 parts of cerasus humilis and 2-5 parts of American ginseng are added into the raw materials according to the parts by weight.
CN202010454764.3A 2020-05-26 2020-05-26 Dietary supplement for promoting microcirculation Pending CN111418841A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010454764.3A CN111418841A (en) 2020-05-26 2020-05-26 Dietary supplement for promoting microcirculation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010454764.3A CN111418841A (en) 2020-05-26 2020-05-26 Dietary supplement for promoting microcirculation

Publications (1)

Publication Number Publication Date
CN111418841A true CN111418841A (en) 2020-07-17

Family

ID=71553093

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010454764.3A Pending CN111418841A (en) 2020-05-26 2020-05-26 Dietary supplement for promoting microcirculation

Country Status (1)

Country Link
CN (1) CN111418841A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115737732A (en) * 2023-01-06 2023-03-07 北京朕荣国际生物科技有限公司 Medicine composition for treating compact osteitis

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103520654A (en) * 2013-10-25 2014-01-22 梁轶聪 Chinese medicine composition for treating knee osteoarthritis and preparation method of Chinese medicine composition
CN104431684A (en) * 2014-11-30 2015-03-25 邵素英 Health product for increasing bone density and preparation method of health product
CN104825652A (en) * 2015-04-28 2015-08-12 广西大学 Traditional Chinese medicine preparation for treating osteoporosis
CN105597030A (en) * 2016-03-08 2016-05-25 付守功 Traditional Chinese medicine composition with functions of dispersing blood stasis and dredging vessels
CN107467330A (en) * 2017-08-23 2017-12-15 李钦超 A kind of pressed candy replenished the calcium for pregnant woman and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103520654A (en) * 2013-10-25 2014-01-22 梁轶聪 Chinese medicine composition for treating knee osteoarthritis and preparation method of Chinese medicine composition
CN104431684A (en) * 2014-11-30 2015-03-25 邵素英 Health product for increasing bone density and preparation method of health product
CN104825652A (en) * 2015-04-28 2015-08-12 广西大学 Traditional Chinese medicine preparation for treating osteoporosis
CN105597030A (en) * 2016-03-08 2016-05-25 付守功 Traditional Chinese medicine composition with functions of dispersing blood stasis and dredging vessels
CN107467330A (en) * 2017-08-23 2017-12-15 李钦超 A kind of pressed candy replenished the calcium for pregnant woman and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
李焕德等: "《临床基本药物手册》", 31 January 2018, 脉络通颗粒 *
臧俊岐: "《颈肩腰腿痛一扫光掌中查》", 30 September 2017, 湖南科学技术出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115737732A (en) * 2023-01-06 2023-03-07 北京朕荣国际生物科技有限公司 Medicine composition for treating compact osteitis

Similar Documents

Publication Publication Date Title
CN101239112B (en) Chinese medicinal composition for regulating blood fat and preparation thereof
CN1318044C (en) Chinese herbal medicine prepn for strengthening kidney-Yang
CN104127699A (en) Vitality-tonifying health-preserving preparation and preparation method thereof
CN102210820A (en) Chinese medicinal composition for treating leukemia
CN101041046A (en) Chinese traditional medicine compound took orally for treating morning diarrhea
CN105878938A (en) Pharmaceutical preparation for treating lung cancer and application thereof
CN109820943B (en) Zhuang medicine preparation for treating gout and preparation method thereof
CN104887747A (en) Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method therefor
CN111418841A (en) Dietary supplement for promoting microcirculation
CN103933450A (en) Traditional Chinese medicine composition for preventing or/and treating gastrointestinal diseases and preparation method of composition
CN104547798A (en) Traditional Chinese medicine preparation for treating chronic enteritis and appendicitis and preparation method thereof
CN106177268A (en) A kind of Chinese medicine composition treating sexual impotence and preparation method thereof
CN105343675A (en) Traditional Chinese medicine preparation for treating adiposis and preparation method thereof
CN102600414B (en) Chinese medicinal composition for treating cervical spondylosis
CN105343808A (en) Traditional Chinese medicine composition with weight reducing effect and preparation method of traditional Chinese medicine composition
CN105362831A (en) Traditional Chinese medicine preparation for treating insomnia
CN105456924A (en) Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof
CN104688999A (en) Chinese herbal preparation for immunity enhancement
CN110478416A (en) The composition and its preparation method and application for treating rheumatic rheumatoid arthritis
CN115252700B (en) Traditional Chinese medicine composition and medicine for treating cervical tinnitus and preparation method thereof
CN104096202B (en) A kind of medicine for treating rotavirus enteritis and preparation method thereof
CN108066735A (en) A kind of Chinese medicine composition for treating chronic nephritis
CN114272344B (en) Traditional Chinese medicine composition for treating qi-yin deficiency and blood stasis type viscera dysfunction, preparation and application
CN114796372B (en) A Chinese medicinal watered pill for treating vitiligo, and its preparation method
CN108785586B (en) Traditional Chinese medicine composition for adjuvant therapy of motor neuron diseases and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination